BBLG: Bone Biologics Corp Financial Statements
Balance sheet, income statement, and cash flow statements for Bone Biologics Corp (BBLG).
$2.32M Market Cap.
BBLG Market Cap. (MRY)
BBLG Shares Outstanding (MRY)
BBLG Assets (MRY)
Total Assets
$3.86M
Total Liabilities
$377.71K
Total Investments
$0
BBLG Income (MRY)
Revenue
$0
Net Income
-$4.11M
Operating Expense
$4.22M
BBLG Cash Flow (MRY)
CF Operations
-$4.12M
CF Investing
$0
CF Financing
$4.42M
BBLG Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $3,861,369 (3.31%) | $3,737,763 (-56.00%) | $8,495,237 (27.26%) | $6,675,365 (0%) |
Assets Current | $3,861,369 (3.31%) | $3,737,763 (-56.00%) | $8,495,237 (27.26%) | $6,675,365 (0%) |
Assets Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $3,483,657 (19.86%) | $2,906,361 (-51.13%) | $5,947,308 (-9.55%) | $6,575,456 (148.02%) |
Property Plant & Equipment Net | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cash & Equivalents | $3,325,131 (9.86%) | $3,026,569 (-59.85%) | $7,538,312 (12.93%) | $6,675,365 (0%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $373,042 (3.43%) | $360,662 (244.19%) | $104,786 (4.88%) | $99,909 (-94.18%) |
Accumulated Retained Earnings (Deficit) | -$85,021,378 (-5.08%) | -$80,908,958 (-12.44%) | -$71,960,227 (-2.11%) | -$70,475,607 (-2.34%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Debt Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Debt Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Liabilities | $377,712 (-54.57%) | $831,402 (-67.37%) | $2,547,929 (2450.25%) | $99,909 (-99.27%) |
Liabilities Current | $377,712 (-54.57%) | $831,402 (-67.37%) | $2,547,929 (2450.25%) | $99,909 (-99.27%) |
Liabilities Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
BBLG Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $2,088,776 (-17.13%) | $2,520,479 (20.84%) | $2,085,875 (104.29%) | $1,021,032 (110.81%) |
Research & Development Expense | $2,130,385 (-69.16%) | $6,907,824 (337.40%) | $1,579,298 (1824.94%) | $82,044 (-75.92%) |
Operating Expenses | $4,219,161 (-55.25%) | $9,428,303 (157.24%) | $3,665,173 (232.27%) | $1,103,076 (33.70%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $805,109 (-19.33%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$4,112,420 (54.04%) | -$8,948,731 (-502.76%) | -$1,484,620 (7.83%) | -$1,610,685 (11.73%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$4,112,420 (54.04%) | -$8,948,731 (-502.76%) | -$1,484,620 (7.83%) | -$1,610,685 (11.73%) |
Preferred Dividends Income Statement Impact | $3,212,504 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$7,324,924 (18.15%) | -$8,948,731 (-502.76%) | -$1,484,620 (7.83%) | -$1,610,685 (11.73%) |
Weighted Average Shares | $252,873 (476.60%) | $43,856 (452.13%) | $7,943 (151.84%) | $3,154 (55.98%) |
Weighted Average Shares Diluted | $252,873 (476.60%) | $43,856 (452.13%) | $7,943 (151.84%) | $3,154 (55.98%) |
Earning Before Interest & Taxes (EBIT) | -$4,112,420 (54.04%) | -$8,948,731 (-502.76%) | -$1,484,620 (-84.29%) | -$805,576 (2.36%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$4,219,161 (55.25%) | -$9,428,303 (-157.24%) | -$3,665,173 (-232.27%) | -$1,103,076 (-33.70%) |
BBLG Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow from Financing | $4,423,497 (-12.30%) | $5,044,161 (13.87%) | $4,429,860 (-43.95%) | $7,903,951 (1862.31%) |
Net Cash Flow from Operations | -$4,124,935 (56.83%) | -$9,555,904 (-167.90%) | -$3,566,913 (-190.33%) | -$1,228,586 (-187.77%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $298,562 (106.62%) | -$4,511,743 (-622.83%) | $862,947 (-87.07%) | $6,675,365 (27746.99%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $1,045,108 (159.47%) |
Issuance (Purchase) of Equity Shares | $4,422,835 (-12.32%) | $5,044,161 (13.87%) | $4,429,860 (-35.41%) | $6,858,843 (0%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $188,819 (23.74%) | $152,599 (-42.77%) | $266,633 (28.79%) | $207,035 (0%) |
Depreciation Amortization & Accretion | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
BBLG Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -211.40% (10.42%) | -236.00% (-774.07%) | -27.00% (-256.07%) | 17.30% (23.57%) |
Return on Average Assets (ROAA) | -195.90% (-26.55%) | -154.80% (-564.38%) | -23.30% (75.40%) | -94.70% (99.86%) |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | -1167.70% (-279.76%) | 649.60% (106.81%) | 314.10% (568.30%) | 47.00% (-15.32%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% |
Price to Earnings Ratio (P/E) | -0.2 (-46.62%) | -0.13 (91.77%) | -1.62 (83.93%) | -10.06 |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | 0.67 (9.20%) | 0.61 (12.78%) | 0.54 (-90.20%) | 5.51 |
Debt to Equity Ratio (D/E) | 0.11 (-62.24%) | 0.29 (-33.18%) | 0.43 (2753.33%) | 0.01 (101.50%) |
Earnings Per Share (EPS) | -28.98 (85.80%) | -204.06 (-9.18%) | -186.9 (62.92%) | -504 (44.44%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -16.31 (92.51%) | -217.89 (51.48%) | -449.06 (-15.28%) | -389.53 (-84.46%) |
Book Value Per Share (BVPS) | 13.78 (-79.21%) | 66.27 (-91.15%) | 748.75 (-64.08%) | 2,084.77 (130.78%) |
Tangible Assets Book Value Per Share (TABVPS) | 15.27 (-82.08%) | 85.23 (-92.03%) | 1,069.53 (-49.47%) | 2,116.45 (0%) |
Enterprise Value Over EBIT (EV/EBIT) | 0 (0%) | 0 (0%) | 1 (101.64%) | -61 |
Enterprise Value Over EBITDA (EV/EBITDA) | 0.3 (1.33%) | 0.3 (-75.92%) | 1.25 (102.05%) | -60.85 |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 10.22 (127.38%) | 4.5 (34.85%) | 3.33 (-95.01%) | 66.81 (0%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$4,124,935 (56.83%) | -$9,555,904 (-167.90%) | -$3,566,913 (-190.33%) | -$1,228,586 (-187.77%) |
Enterprise Value (EV) | -$1,249,965 (53.39%) | -$2,681,655 (-44.92%) | -$1,850,417 (-103.78%) | $49,016,033 |
Earnings Before Tax (EBT) | -$4,112,420 (54.04%) | -$8,948,731 (-502.76%) | -$1,484,620 (7.83%) | -$1,610,685 (11.65%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$4,112,420 (54.04%) | -$8,948,731 (-502.76%) | -$1,484,620 (-84.29%) | -$805,576 (2.36%) |
Invested Capital | $158,526 (231.88%) | -$120,208 (92.44%) | -$1,591,004 (-1492.45%) | -$99,909 (94.93%) |
Working Capital | $3,483,657 (19.86%) | $2,906,361 (-51.13%) | $5,947,308 (-9.55%) | $6,575,456 (148.02%) |
Tangible Asset Value | $3,861,369 (3.31%) | $3,737,763 (-56.00%) | $8,495,237 (27.26%) | $6,675,365 (0%) |
Market Capitalization | $2,316,461 (30.80%) | $1,770,931 (-44.81%) | $3,208,826 (-91.15%) | $36,251,511 |
Average Equity | $3,464,994 (-8.60%) | $3,791,165 (-30.99%) | $5,493,964 (158.93%) | -$9,322,454 (28.62%) |
Average Assets | $3,740,056 (-35.30%) | $5,780,227 (-9.15%) | $6,362,202 (274.06%) | $1,700,840 (62569.12%) |
Invested Capital Average | $352,180 (125.56%) | -$1,377,656 (-191.44%) | -$472,702 (72.45%) | -$1,715,784 (-15.36%) |
Shares | 410,589 (528.77%) | 65,300 (514.53%) | 10,626 (48.57%) | 7,152 (-16.09%) |
